On December 25, Wen Wei, general manager of Shenzhen Sinonuclear Haidewei Biotechnology Co., Ltd. visited ROBO Medical and had in-depth exchanges with Yang Jialin, general manager of ROBO Medical and relevant personnel of the company. The exchange aims to further strengthen the cooperation between the two sides and jointly promote the development of the digestive medicine industry.
General Manager Wen Wei and his delegation visited the research and development laboratory and office site of ROBO Medical, and learned about the research and development status of EndoFaster digestive endoscopic surgery auxiliary robot system, multi-channel digestive endoscopic surgery robot system and TARZAN agile intelligent lower limb rehabilitation robot originally developed by ROBO. He also said that CNNC Haidewei and ROBO Medical have broad cooperation space in many fields, hoping that the two sides can further strengthen exchanges and jointly explore cooperation opportunities.
Yang Jialin, general manager of ROBO Medical, introduced the company's development history, business areas and technical advantages. He said that ROBO Medical focuses on the development and production of intelligent medical robots to provide efficient and accurate solutions for doctors and patients. In the future, the company will continue to increase investment in research and development, launch more innovative products, and contribute to the development of the medical robot industry.
This exchange has laid a good foundation for future cooperation between the two sides. ROBO Medical looks forward to in-depth cooperation with CNNC Hydewell in research and development, sales, financing and other fields to jointly promote the development of the medical robot industry and make greater contributions to the cause of human health.
